End-stage Renal Disease Clinical Trial
Official title:
Social Network Interventions to Reduce Race Disparities in Living Kidney Donation
NCT number | NCT05255757 |
Other study ID # | 849197 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | October 12, 2021 |
Est. completion date | April 1, 2024 |
For this current phase of the larger project, the investigators will survey transplant candidates as well as the participants family and friends to understand the barriers to volunteering and evaluation. This project will examine how network characteristics are associated with eventual living donor kidney transplant outcomes and test the efficacy of evidence-based interventions designed to assist kidney transplant candidates in participant donor search on a multi-center scale.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | April 1, 2024 |
Est. primary completion date | April 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Are KT candidates at the University of Pennsylvania or University of Alabama-Birmingham OR were identified by KT candidate from the University of Pennsylvania or University of Alabama-Birmingham as a network member - Are adults aged 18 or older - Are able and willing to consent to participation in the survey Exclusion Criteria: - Person is not a KT candidate at University of Pennsylvania or University of Alabama-Birmingham OR was NOT identified by KT candidate from University of Pennsylvania or University of Alabama-Birmingham as a network member - Individuals who are not yet 18 - Participant does not speak English |
Country | Name | City | State |
---|---|---|---|
United States | University of Alabama-Birmingham | Birmingham | Alabama |
United States | Penn Medicine-- University of Pennsylvania | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Penn State University | University of Alabama at Birmingham, University of Pennsylvania |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Received a living donor kidney transplant | Living donor kidney transplant received by patient | up to 3 years | |
Primary | Received a deceased donor kidney transplant | Deceased donor kidney transplant received by patient | up to 3 years | |
Primary | Death | Patient died during the follow-up period | up to 3 years | |
Primary | Completed living kidney donor screening questionnaires | Number of completed living kidney donation screening questionnaires completed for patient | up to 3 years | |
Primary | Preliminary approval from living kidney donor screening questionnaires | Number of completed living kidney donor screening that received preliminary approval for patient | up to 3 years | |
Primary | Completed living kidney donor evaluations | Number of living kidney donor evaluations completed for patient | up to 3 years | |
Primary | Approvals for living kidney donor candidacy | Number of completed living kidney donor evaluations that resulted in approved living kidney donor candidacy for patient | up to 3 years | |
Secondary | Preference for living kidney donor | A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding preference for living kidney donor | Immediate | |
Secondary | Concerns about living kidney donation | A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding concerns for living kidney donation | Immediate | |
Secondary | Living donor kidney transplant willingness | A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding living donor kidney transplant willingness | Immediate | |
Secondary | Self-rated kidney transplant knowledge | Respondent is asked to rate their level of knowledge related to kidney transplantation. | Immediate | |
Secondary | Trust in medical institutions | Respondent is asked to rate their trust in medical institutions. | Immediate | |
Secondary | Religious views' effect on kidney transplant willingness | Respondent is asked how strongly they agree that their religious views affect their willingness to pursue a kidney transplant. | Immediate |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04087213 -
Study of HemoCareā¢ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD
|
N/A | |
Completed |
NCT02207088 -
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
|
Phase 3 | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Completed |
NCT02237521 -
The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease
|
N/A | |
Withdrawn |
NCT01691196 -
Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
|
||
Completed |
NCT01394341 -
Liraglutide Treatment to Patients With Severe Renal Insufficiency
|
Phase 4 | |
Active, not recruiting |
NCT00247507 -
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT00307463 -
Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
|
Phase 4 | |
Recruiting |
NCT00155363 -
Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis
|
Phase 4 | |
Completed |
NCT00234156 -
The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers
|
N/A | |
Completed |
NCT00586131 -
Arterial pH and Total Body Nitrogen Balances in APD
|
Phase 4 | |
Active, not recruiting |
NCT05027074 -
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
|
Phase 2 | |
Recruiting |
NCT04575077 -
The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
|
||
Enrolling by invitation |
NCT05001009 -
Goals of Care Conversations Study
|
N/A | |
Completed |
NCT01756508 -
Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
|
Phase 2 | |
Recruiting |
NCT03862859 -
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
|
Phase 4 | |
Terminated |
NCT03661229 -
Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device
|
N/A | |
Completed |
NCT03288922 -
Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF
|
N/A | |
Completed |
NCT02572882 -
Gut Microbiome and p-Inulin in Hemodialysis
|
N/A | |
Completed |
NCT02360748 -
A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients
|
N/A |